On November 8, 2017 Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, reported that it will webcast corporate presentations at the following investor conferences in November (Press release, Keryx Biopharmaceuticals, NOV 8, 2017, View Source/phoenix.zhtml?c=122201&" target="_blank" title="View Source/phoenix.zhtml?c=122201&" rel="nofollow">View Source;p=RssLanding&cat=news&id=2315586 [SID1234521798]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel’s 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017 at 3:30 p.m. ET
Jefferies’ 2017 Global Healthcare Conference in London, UK, on Thursday, November 16, 2017 at 8:40 a.m. GMT (3:40 a.m. ET)
A fireside chat at the 29th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 28, 2017 at 2:00 p.m. ET
Live audio webcasts of the presentations will be accessible from Keryx Biopharmaceuticals’ website at View Source within the Investor Relations section under "webcasts and presentations." An archived version of the webcast will be available for at least 15 days following the conclusion of the live presentations.